Fred Vitale

This is a page dedicated to get more information for investors to evaluate the management style of Fred Vitale who is a Chief Bus. Officer and VP of Hana Biosciences, Inc.

Here on this page we are inviting all readers to discuss Fred Vitale. You may anonymously post comments with any information that they have about Fred Vitale. You can post comments about their management style or whatever you want to talk about concerning their ability as an executive. Please refrain from personal attacks.

Here is a copy of personal Bio that we found:

Fred Vitale has served as Vice President, Business Development of Hana since January 2004. From April 2001 to January 2004, Mr. Vitale was employed by Genentech, where he served as head of commercial Rituxan (rituximab) and pre-launch medical education for Avastin (bevacizumab). From December 1998 to April 2001, Mr. Vitale was Director, Global Oncology Marketing at Bristol-Myers Squibb where he was responsible for pipeline development, licensing, and life cycle management for cancer products including Taxol (paclitaxel); as well as Director of Operations and Planning for Japan and China. Prior to that, Mr. Vitale held several roles of increasing responsibility in sales, marketing and general management at Amgen from January 1990 to December 1998. Mr. Vitale received a Bachelor of Science in Biology from The Citadel in Charleston, South Carolina and a Physician Assistant degree from the Medical University of South Carolina.